Sarcoid‐like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab

Immune checkpoint inhibitors (ICIs) have become the standard of care for the treatment of non‐small cell lung cancer (NSCLC). With the increasing use of ICIs, clinicians should be familiar with their immune‐related adverse events, including sarcoid‐like reactions, which have been associated with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamori, Shinkichi, Furubayashi, Nobuki, Taguchi, Kenichi, Matsubara, Taichi, Fujishita, Takatoshi, Ito, Kensaku, Yamaguchi, Masafumi, Toyozawa, Ryo, Seto, Takashi, Negishi, Takahito, Nakamura, Motonobu, Okamoto, Tatsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287006/
https://www.ncbi.nlm.nih.gov/pubmed/34002950
http://dx.doi.org/10.1111/1759-7714.14011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287006/
https://www.ncbi.nlm.nih.gov/pubmed/34002950
http://dx.doi.org/10.1111/1759-7714.14011

Ejemplares similares